从颈动脉内膜切除术到经股动脉颈动脉支架置入术再到TCAR:颈动脉疾病内外科管理的演变
本文综述大型临床研究证据,梳理颈动脉狭窄管理演变:颈动脉内膜切除术(CEA)仍是症状性>50%狭窄及无症状高级别狭窄的治疗选择;经股动脉颈动脉支架置入术(TF-CAS)因CEA优效而适应证缩小;经颈动脉血运重建术(TCAR)近5年显示围术期并发症较CEA和TF-CAS显著减少,但尚无随机对照试验比较;新药物改变斑块形态使无症状颈动脉疾病手术指征是否重审再受关注。
要点
- CEA是症状性>50%颈动脉狭窄及无症状高级别狭窄的治疗选择。
- 多项大型随机对照试验显示CEA优于TF-CAS,后者作为首选术式的适应证已缩小。
- TCAR围术期并发症较CEA和TF-CAS显著减少,但尚无随机对照试验比较。
核心结论
- 颈动脉狭窄现代管理已从CEA经TF-CAS演变至TCAR,TCAR显示围术期并发症较CEA和TF-CAS显著减少但缺乏随机对照试验比较。
- 新药物被证明可成功改变斑块形态,使无症状颈动脉疾病手术指征是否应重新审视再受关注。
研究设计与样本
- 综述,汇总多项大型临床研究及随机临床试验的科学证据,未报告检索范围。
主要发现
- 多项大型随机临床试验确立CEA为症状性>50%颈动脉狭窄或无症�状高级别颈动脉狭窄患者的治疗选择。
- 多项大型随机对照试验证明CEA优于TF-CAS后,TF-CAS作为所有颈动脉疾病患者首选初始术式的适应证已减少。
- 近5年引入的TCAR较CEA和TF-CAS显示围术期并发症发生率显著降低,但尚无随机对照试验比较TCAR与CEA或TF-CAS。
关键数值与推荐
- CEA为症状性>50%颈动脉狭窄或无症状高级别颈动脉狭窄的治疗选择。
- TF-CAS作为所有患者首选初始术式的适应证已减少。
- TCAR围术期并发症较CEA和TF-CAS显著减少,但无随机对照试验比较。
临床怎么用
- 原文未据此给出推荐。
局限性
- 尚无随机对照试验比较TCAR与CEA或TF-CAS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with carotid stenosis can be broadly classified into 2 categories: symptomatic and asymptomatic. While there is little disagreement about surgical management of symptomatic carotid stenosis, the optimal management strategy for the patients with asymptomatic carotid disease has undergone significant evolution over past 5 decades. With increasing focus on role of plaque morphology on the etiology of symptoms, there has been an increased focus on optimizing the medical management targeted at plaque stabilization, especially for the patients with asymptomatic carotid disease, while reserving the most aggressive surgical treatment options for the patients with symptomatic carotid stenosis. This review summarizes the scientific evidence based on multiple large clinical studies showing how the modern-day management of carotid stenosis has evolved. Multiple, large randomized clinical trials have established carotid endarterectomy (CEA) as the treatment of choice for symptomatic patients with symptomatic, >50% stenosis of carotid artery or those who have asymptomatic high-grade carotid stenosis. With the advancements in endovascular techniques, the technique of transfemoral carotid artery stenting (TF-CAS) was popularized, but after multiple, large randomized controlled trials demonstrated superiority of CEA, the indications for TF-CAS as the initial operation of choice for carotid disease for all patients have been reduced. In the past 5 years, the introduction of the newer technique of trans carotid artery revascularization (TCAR) has shown promising results with significant reduction in the incidence of perioperative complications as compared to CEA and TF-CAS; however, there have been no randomized controlled trials comparing TCAR to either CEA or TF-CAS. Moreover, with the developments in the medical field with introduction of several new medications which have been demonstrated to successfully change the plaque morphology, there has been a renewed interest in exploring if the indications for surgical management for the asymptomatic carotid disease should be revisited.
引用
- Hakimi A, Choi ES, Aziz FF, et al. Evolution of Medical and Surgical Management of Carotid Disease from Carotid Endarterectomy to Transfemoral Carotid Stenting to TCAR. Ann Vasc Surg. 2024. PMID: 39332702. doi:10.1016/j.avsg.2024.09.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。